𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Class II radical hysterectomy for stage I–IIA cervix cancer: Prognostic factors associated to recurrence and survival in a northeast Brazil experience

✍ Scribed by Artur Lício Rocha Bezerra; Mário Rino Martins; Simone Maria Muniz da Silva Bezerra; José Natal Figueiroa; Thales Paulo Batista


Book ID
102923594
Publisher
John Wiley and Sons
Year
2011
Tongue
English
Weight
664 KB
Volume
104
Category
Article
ISSN
0022-4790

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

Background

The main aim of this study was describe the author's experience with class II radical hysterectomy and pelvic lymphadenectomy to treat stage I–IIA cervix cancer and reexamine some prognostic factors associated with disease recurrence and patient survival in this data from northeast Brazil.

Methods

A cross‐sectional study was carried out on patients treated at our Centers from January 2001 to December 2008. Statistical analyses were performed using conventional methods.

Results

Eighty‐eight patients were selected to analysis. Over the 7.3‐year follow‐up, 80 (91%) patients were alive and 8 (9%) disease recurrences were observed. Overall 1‐, 2‐, and 5‐year patients survival was 96.5%, 95.3%, and 84%, respectively. Recurrence was associated to tumor size ≥1 cm (P = 0.021) and compromised vaginal margin (P = 0.020). Lower survivals were associated to tumor size ≥1 cm (P = 0.038), compromised vaginal margin (P < 0.001), and lymph node metastasis (P = 0.024). Postoperative complications (n = 11) included wound infection (5.7%), partial wound dehiscence (3.4%), and bladder atony (3.4%).

Conclusions

Class II radical hysterectomy has provided appropriated disease control of cervix cancer with low morbidity in our experience. Furthermore, tumor size and compromised vaginal margin were significantly associated to recurrence. These factors and lymph node metastasis were also associated to lower 5‐year survival according to our analysis. J. Surg. Oncol. 2011; 104:255–259. © 2011 Wiley‐Liss, Inc.